India · Delayed Price · Currency is INR Sakar Healthcare Statistics
Total Valuation
NSE:SAKAR has a market cap or net worth of INR 23.90 billion. The enterprise value is 24.51 billion.
| Market Cap | 23.90B |
| Enterprise Value | 24.51B |
Important Dates
The next estimated earnings date is Friday, February 5, 2027.
| Earnings Date | Feb 5, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:SAKAR has 22.25 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 22.25M |
| Shares Outstanding | 22.25M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 51.39% |
| Owned by Institutions (%) | n/a |
| Float | 5.27M |
Valuation Ratios
The trailing PE ratio is 55.57 and the forward PE ratio is 46.77.
| PE Ratio | 55.57 |
| Forward PE | 46.77 |
| PS Ratio | 7.89 |
| PB Ratio | 6.91 |
| P/TBV Ratio | 7.17 |
| P/FCF Ratio | 124.90 |
| P/OCF Ratio | 56.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.49, with an EV/FCF ratio of 128.14.
| EV / Earnings | 57.19 |
| EV / Sales | 8.10 |
| EV / EBITDA | 27.49 |
| EV / EBIT | 36.95 |
| EV / FCF | 128.14 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.34 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.70 |
| Debt / FCF | 3.25 |
| Interest Coverage | 8.61 |
Financial Efficiency
Return on equity (ROE) is 13.20% and return on invested capital (ROIC) is 11.89%.
| Return on Equity (ROE) | 13.20% |
| Return on Assets (ROA) | 8.60% |
| Return on Invested Capital (ROIC) | 11.89% |
| Return on Capital Employed (ROCE) | 16.76% |
| Weighted Average Cost of Capital (WACC) | 6.78% |
| Revenue Per Employee | 6.96M |
| Profits Per Employee | 985,409 |
| Employee Count | 435 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, NSE:SAKAR has paid 167.48 million in taxes.
| Income Tax | 167.48M |
| Effective Tax Rate | 28.09% |
Stock Price Statistics
The stock price has increased by +165.37% in the last 52 weeks. The beta is 0.45, so NSE:SAKAR's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +165.37% |
| 50-Day Moving Average | 1,036.99 |
| 200-Day Moving Average | 772.22 |
| Relative Strength Index (RSI) | 58.76 |
| Average Volume (20 Days) | 150,029 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SAKAR had revenue of INR 3.03 billion and earned 428.65 million in profits. Earnings per share was 19.32.
| Revenue | 3.03B |
| Gross Profit | 1.57B |
| Operating Income | 663.52M |
| Pretax Income | 596.14M |
| Net Income | 428.65M |
| EBITDA | 891.59M |
| EBIT | 663.52M |
| Earnings Per Share (EPS) | 19.32 |
Balance Sheet
The company has 2.65 million in cash and 621.51 million in debt, with a net cash position of -618.86 million or -27.81 per share.
| Cash & Cash Equivalents | 2.65M |
| Total Debt | 621.51M |
| Net Cash | -618.86M |
| Net Cash Per Share | -27.81 |
| Equity (Book Value) | 3.46B |
| Book Value Per Share | 155.50 |
| Working Capital | 406.72M |
Cash Flow
In the last 12 months, operating cash flow was 421.27 million and capital expenditures -229.97 million, giving a free cash flow of 191.31 million.
| Operating Cash Flow | 421.27M |
| Capital Expenditures | -229.97M |
| Depreciation & Amortization | 228.07M |
| Net Borrowing | -122.45M |
| Free Cash Flow | 191.31M |
| FCF Per Share | 8.60 |
Margins
Gross margin is 51.83%, with operating and profit margins of 21.91% and 14.16%.
| Gross Margin | 51.83% |
| Operating Margin | 21.91% |
| Pretax Margin | 19.69% |
| Profit Margin | 14.16% |
| EBITDA Margin | 29.44% |
| EBIT Margin | 21.91% |
| FCF Margin | 6.32% |
Dividends & Yields
NSE:SAKAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
| Earnings Yield | 1.80% |
| FCF Yield | 0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |